AMEX (USD): NovaBay Pharmaceuticals, Inc. (NBY)
Last Price
0.84
Today's Change
+0.343 (69.01%)
Day's Change
0.616 - 0.94
Trading Volume
125,332,097
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
World to Pay to Turn Off Green Power Unless Grids Improve
2
US Housing Starts Increase to Fastest Pace Since April
3
Elon Musk’s X Bypasses Brazil Ban Through Software Update
4
US Mortgage Rates Drop to Two-year Low Ahead of US Fed Rate Cut
5
BofA Now Expects US Fed to Go for 75-bp Cut in 4Q After Bumper Rate Reduction
#
Stock
Score
ZEO
Zeo Energy Corp.
GOOGL
Alphabet Inc.
833
AGN
666
PLTR
Palantir Technologies Inc.
566
BABA
Alibaba Group Holding Limited
6
AAPL
Apple Inc.
500
7
FB
400
8
BAC
Bank of America Corporation
333
9
CBM
10
ALAI
Alger AI Enablers & Adopters ETF
Last
Change
Volume
XPON
0.088
+0.029
1,422,045,377
NVDA
116.23
-1.635
208,124,177
VERB
0.07
+0.014
154,164,799
CERO
0.126
+0.039
145,579,421
NBY
+0.343
SQQQ
7.85
+0.095
125,242,465
LMDX
0.016
-0.018
120,553,903
SOXL
33.06
-2.06
86,338,664
762.00
-84.71
85,558,284
HOLO
0.243
+0.011
79,760,086
CEG
253.46
+44.96
11,392,573
BKNG
4,044.01
+26.50
185,425
RYVLX
530.29
+25.87
0
RYVYX
530.12
+25.86
FCNCA
1,958.33
+18.76
71,570
RYCCX
381.75
+18.62
CRWD
295.91
+18.53
7,826,982
MOG-B
203.00
+16.48
206
RYSIX
431.84
+15.79
TPL
931.44
+15.78
68,162
BRK-A
681,592.80
-6,247.187
1,290
MELI
1,629.32
-188.66
1,851,535
MSTR
1,309.00
-138.99
2,237,917
NVR
9,528.50
-131.145
11,580
MKL
1,395.13
-102.30
318,280
MPWR
838.63
-96.05
902,546
NOW
643.29
-87.83
5,025,012
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....